miRNA dysregulation is an emerging modulator of genomic instability

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Genomic instability, characterized by genetic alterations, is a hallmark of cancer, driving tumor heterogeneity and drug resistance.
• Defects in DNA repair, surveillance, and mitotic checkpoints contribute to genome instability and malignant transformation.
• MicroRNAs (miRNAs), small non-coding RNAs, are epigenetic regulators with dysregulated expression in many cancers.

Purpose of the Study:

• To review the role of miRNA dysregulation in inducing genomic instability.
• To explore the mechanistic links between specific miRNAs and genome instability subtypes.
• To identify knowledge gaps and suggest future research directions in this field.

Main Methods:

• Literature review focusing on mechanistic studies.
• Analysis of research linking miRNA dysregulation to specific modes of genome instability.
• Synthesis of current knowledge on miRNA's role in carcinogenesis.

Main Results:

• miRNA dysregulation is increasingly recognized as a causal factor in initiating genomic instability.
• Specific miRNAs have been mechanistically linked to various types of genetic alterations.
• This dysregulation contributes significantly to the development and progression of cancer.

Conclusions:

• miRNA dysregulation is a critical step in the induction of genomic instability and subsequent carcinogenesis.
• Further mechanistic studies are needed to fully elucidate these complex interactions.
• Addressing knowledge gaps will pave the way for novel therapeutic strategies targeting miRNA pathways in cancer.